Integra LifeSciences Corp. regulatory update

The Burnham Institute (La Jolla, Calif.) received U.S. Patent No. 5,672,585 covering compounds based on the peptide sequence arginine-glycine-aspartic acid (RGD) to treat thrombosis. The patent is lic...